Send to:

Choose Destination
See comment in PubMed Commons below
Clin Cancer Res. 2006 Sep 15;12(18):5277-87.

The use of targeted mouse models for preclinical testing of novel cancer therapeutics.

Author information

  • 1Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania, USA.


The use of genetically engineered cancer-prone mice as relevant surrogates for patients during the development of pertinent clinical applications is an unproven expectation that awaits direct demonstration. Despite the generally disappointing findings using tumor xenografts and certain early transgenic cancer models to predict therapeutic efficacy in patients, the dramatic progress of mouse models in recent years engenders optimism that the newest generation of mouse models will provide a higher standard of predictive utility in the process of drug development.

[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk